GLP-1 effects, including the appetite suppression most people notice first, activate at moderate potency but become more pronounced as doses increase during titration
The presence of a detectable inactive oxidized form of GSTP1-1 has been recently found in salivary samples of healthy human subjects
Unexplained severe abdominal pain during treatment should prompt immediate medical evaluation and temporary discontinuation of the peptide until pancreatitis is ruled out
N Engl J Med 375:311322 Ahrn B, Masmiquel L, Kumar H, Sargin M, Karsbl JD, Jacobsen SH, Chow F (2017) Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised trial
Dipeptidyl peptidase-4 inhibition with saxagliptin ameliorates angiotensin II-induced cardiac diastolic dysfunction in male mice